Isabel Teresa
Rubio
Consultora Médica
University of Milan
Milán, ItaliaPublications in collaboration with researchers from University of Milan (18)
2024
-
EUSOMA quality indicators for non-metastatic breast cancer: An update
European Journal of Cancer, Vol. 198
-
Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network
European Journal of Cancer, Vol. 196
2023
-
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy
European Journal of Cancer, Vol. 181, pp. 79-91
-
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
The Lancet Oncology, Vol. 24, Núm. 1, pp. e11-e56
-
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care
European Journal of Cancer, Vol. 187, pp. 105-113
-
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus
eClinicalMedicine, Vol. 61
-
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023
Annals of Oncology
2022
-
The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres
European Journal of Cancer, Vol. 177, pp. 72-79
2021
-
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
The Lancet Oncology, Vol. 22, Núm. 4, pp. 476-488
-
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
The Lancet Oncology, Vol. 22, Núm. 1, pp. e18-e28
2019
-
About the French prohibition of textured breast implants: is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position
Breast
-
Corrigendum to “About the French prohibition of textured breast implants: Is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position” (The Breast (2019) 46 (95–96), (S0960977619304990), (10.1016/j.breast.2019.05.005))
Breast
-
Corrigendum to “EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants” (The Breast (2019) 44 (90–93), (S0960977619300116), (10.1016/j.breast.2019.01.011))
Breast
-
EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants
Breast, Vol. 44, pp. 90-93
-
European guidelines on the organisation of breast centres and voluntary certification processes
Breast Care, Vol. 14, Núm. 6, pp. 359-365
2018
-
Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?
Breast, Vol. 41, pp. 133-135
2016
-
70-Gene signature as an aid to treatment decisions in early-stage breast cancer
New England Journal of Medicine, Vol. 375, Núm. 8, pp. 717-729
2011
-
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase
European Journal of Cancer, Vol. 47, Núm. 18, pp. 2742-2749